Stay updated with breaking news from Merck Sharp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Last week, the Federal Circuit handed down its opinion in Pfizer Inc. v. Sanofi Pasteur Inc., affirming the Patent Trial and Appeal Board's (PTAB) determination that all claims of U.S....
Trial will evaluate IDE161, IDEAYA's investigational PARG inhibitor, in combination with KEYTRUDA® , Merck's anti-PD-1 therapy, in patients with MSI-high and MSS endometrial cancer Potential...
Perhaps one of your patients would benefit from enrolling in a new clinical trial in leukemia or lymphoma?
When thinking about his legacy as a Montgomery County Commissioner, Ken Lawrence Jr. took inspiration from Broadway, quoting a line from Hamilton.
Posts fourth quarter revenues of $2.8 billion, GAAP net income of $217 million and GAAP diluted EPS of $0.55Reports full-year revenues of $6.8 billion, GAAP net loss of $(4.7) billion and GAAP diluted EPS of $(12.33); loss primarily driven by mostly non-cash charges of $3.7 billion related to resizing and a tax valu...